Discover
LXRX
Lexicon Pharmaceuticals, Inc.
2.31
22 x 2.31
44 x 2.32
bid
ask
-
0.07
2.94%
12:07 PM
timesize
| Ytd | 100.87% | |
| 1y | 92.50% |
2.23
day range
2.37
1.00
52 week range
2.68
| Open | 2.36 | Prev Close | 2.38 | Low | 2.23 | High | 2.37 | Mkt Cap | 1.06B |
| Vol | 1.31M | Avg Vol | 3.31M | EPS | -0.07 | P/E | -32.78 | Forward P/E | -11.00 |
| Beta | 1.05 | Short Ratio | 12.78 | Inst. Own | 78.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 2.17 | 200-d Avg | 1.64 | 1yr Est | 3.77 |
| Income Statement | |||
| Total Revenue | 21.10M | ||
| Revenues (USD) | 21.10M | ||
| Cost of Revenue | 108.00K | ||
| Gross Profit | 20.99M | ||
| Operating Expenses | 21.99M | ||
| Research and Development Expense | 12.76M | ||
| Selling, General and Administrative Expense | 9.23M | ||
| Operating Income | -996.00K | ||
| Interest Expense | 1.59M | ||
| Net Income | -1.04M | ||
| Net Income Common Stock | -1.04M | ||
| Net Income Common Stock (USD) | -1.04M | ||
| Consolidated Income | -1.04M | ||
| Earning Before Interest & Taxes (EBIT) | 547.00K | ||
| Earning Before Interest & Taxes (USD) | 547.00K | ||
| Weighted Average Shares | 400.24M | ||
| Weighted Average Shares Diluted | 400.24M | ||
| Balance Sheet | |||
| Cash and Equivalents | 67.09M | ||
| Cash and Equivalents (USD) | 67.09M | ||
| Investments | 132.57M | ||
| Investments Current | 132.57M | ||
| Trade and Non-Trade Receivables | 11.78M | ||
| Current Assets | 186.03M | ||
| Property, Plant & Equipment Net | 8.88M | ||
| Total Assets | 268.82M | ||
| Total Debt | 49.68M | ||
| Current Liabilities | 9.90M | ||
| Debt Non-Current | 49.68M | ||
| Total Liabilities | 65.96M | ||
| Accumulated Retained Earnings (Deficit) | -2.02B | ||
| Accumulated Other Comprehensive Income | -130.00K | ||
| Shareholders Equity | 202.86M | ||
| Shareholders Equity (USD) | 202.86M | ||
| Assets Non-Current | 82.79M | ||
| Total Debt (USD) | 49.68M | ||
| Goodwill and Intangible Assets | 44.54M | ||
| Inventory | 276.00K | ||
| Liabilities Non-Current | 56.07M | ||
| Trade and Non-Trade Payables | 3.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 110.00K | ||
| Net Cash Flow from Financing | 88.76M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.76M | ||
| Issuance (Purchase) of Equity Shares | 70.05M | ||
| Issuance (Repayment) of Debt Securities | -5.00M | ||
| Net Cash Flow from Investing | -70.26M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -70.26M | ||
| Net Cash Flow from Operations | -14.73M | ||
| Share Based Compensation | 3.08M | ||